Clinical Trials Related to Muscle Invasive Bladder Cancer

Related studies linked through entity extraction aliases.

BLASST-1 (Bladder Cancer Signal Seeking Trial): Nivolumab, Gemcitabine, and Cisplatin in Treatment of Muscle Invasive Bladder Cancer (MIBC) Undergoing Cystectomy

Status: COMPLETED
Phase: PHASE2

Radical Cystectomy Compared With Chemoradiation for Muscle Invasive Bladder Cancer

Status: TERMINATED
Phase: NA

Basal Like Bladder Cancer : Signature and Therapeutic

Status: UNKNOWN
Phase: N/A

Open-Label, Randomised, Multi-Drug, Biomarker-Directed, Phase 1b Study in Pts w/ Muscle Invasive Bladder Cancer

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1

Dose Dense MVAC for Muscle Invasive Bladder Cancer

Status: COMPLETED
Phase: PHASE2